Burger Menu

Site by


Quibim, a global leader in whole-body automated medical imaging analysis, follows an AI-powered approach to help detect pathologies across every body part and imaging modality. We believe evidence-based research and technological innovation combined together help save lives. We are on a mission to improve human health through AI-guided precision medicine. We understand every body part. We speak human.

Quibim is the go-to radiomics partner, providing a solution for everybody part that identifies and locates anomalies on X-rays, MRIs, and CT scans utilizing deep learning technology and millions of medical images. These solutions are meant to expedite the manner radiologists read and interpret the medical images, hence contributing to the early detection of diseases in different body parts. Using the power and promise of quantified data and artificial intelligence we make precision medicine a reality.

Additionally, Quibim supports its partners in providing solutions for clinical studies. From radiomics profiling to database insights, and companion diagnostic development. We solve your most pressing demands and difficulties, using the power and promise of data and artificial intelligence. We make precision medicine a reality. 

We aim to create a shift in the world of patient care by understanding the whole-body system instead of being organ-based. In addition, we deeply analyze disease mechanisms and monitor treatment progress, using the latest AI-driven technology. With this innovation, we strive to accelerate the radiologists’ and clinicians' workflow to improve patient care through better science, deeper quantitative insights, and stronger relationships. The better equipped we are, the more we can assist healthcare professionals in making the best treatment options for their patients.

About the founders/CEO:

Quibim was founded by Dr. Ángel Alberich-Bayarri and Prof. Luis Marti-Bonmati, two innovators at the forefront of medical imaging. They established the process for the development of biomarkers, adopted in 2013 by the European Society of Radiology (ESR) as the official industry standard. They again set a benchmark when, in March 2020, Quibim became the main AI platform for screening for COVID-19 across Europe. Shortly after, the Radiological Society of North America (RSNA), with more than 52,000 members from 153 countries, joined the initiative with the goal of creating a global medical repository of COVID-19 cases, with the European arm running on Quibim Precision®. 
Before founding Quibim, Dr. Ángel Alberich-Bayarri worked first as a telecom engineer for the University of Valencia and then for various R&D projects, for two hospitals and for SEDIA Investiga. He also worked for the Grupo Universitario Quiron in R&D. Dr. Ángel Alberich-Bayarri holds a PhD in Engineering and Biomedical Engineering one in from the Universitat Politècnica de València. He is Quibim's CEO.
< Back Home